Estrella Immunopharma (ESLA) Short Interest Ratio & Short Volume → Heard about the 72-Hour Profit Surge? Read this… (From DTI) (Ad) Free ESLA Stock Alerts $0.88 -0.13 (-12.87%) (As of 05/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrends Estrella Immunopharma Short Interest DataCurrent Short Interest9,200 sharesPrevious Short Interest11,300 sharesChange Vs. Previous Month-18.58%Dollar Volume Sold Short$9,936.00Short Interest Ratio0.3 Days to CoverLast Record DateMay 15, 2024Outstanding Shares36,380,000 sharesFloat Size9,290,000 sharesShort Percent of Float0.10%Today's Trading Volume41,941 sharesAverage Trading Volume32,645 sharesToday's Volume Vs. Average128% Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartESLA Short Interest Over TimeESLA Days to Cover Over TimeESLA Percentage of Float Shorted Over Time Ad WealthPressThe Tesla Indicator Is BullishIf you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward…>> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo Estrella Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20249,200 shares $9,936.00 -18.6%0.1%0.3 $1.08 4/30/202411,300 shares $11,865.00 +145.7%0.1%0.4 $1.05 4/15/20244,600 shares $4,876.00 -41.8%0.1%0.2 $1.06 3/31/20247,900 shares $9,796.00 +61.2%0.1%0.2 $1.24 3/15/20244,900 shares $5,439.00 -88.1%0.1%0.1 $1.11 2/29/202441,100 shares $41,922.00 -28.0%0.5%1 $1.02 2/15/202457,100 shares $62,239.00 +117.9%0.7%1.2 $1.09 1/31/202426,200 shares $29,344.00 No Change0.3%0.5 $1.12 ESLA Short Interest - Frequently Asked Questions What is Estrella Immunopharma's current short interest? Short interest is the volume of Estrella Immunopharma shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 9,200 shares of ESLA short. 0.10% of Estrella Immunopharma's shares are currently sold short. Learn More on Estrella Immunopharma's current short interest. What is a good short interest percentage for Estrella Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of Estrella Immunopharma's floating shares are currently sold short. Is Estrella Immunopharma's short interest increasing or decreasing? Estrella Immunopharma saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 9,200 shares, a decline of 18.6% from the previous total of 11,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Estrella Immunopharma's float size? Estrella Immunopharma currently has issued a total of 36,380,000 shares. Some of Estrella Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Estrella Immunopharma currently has a public float of 9,290,000 shares. How does Estrella Immunopharma's short interest compare to its competitors? 0.10% of Estrella Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Estrella Immunopharma: Molecular Partners AG (0.14%), Vigil Neuroscience, Inc. (5.93%), aTyr Pharma, Inc. (0.50%), Sangamo Therapeutics, Inc. (7.10%), DBV Technologies S.A. (0.27%), Omega Therapeutics, Inc. (24.22%), bluebird bio, Inc. (28.90%), Cognition Therapeutics, Inc. (0.40%), Athira Pharma, Inc. (2.62%), Precision BioSciences, Inc. (9.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Estrella Immunopharma stock? Short selling ESLA is an investing strategy that aims to generate trading profit from Estrella Immunopharma as its price is falling. ESLA shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Estrella Immunopharma? A short squeeze for Estrella Immunopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ESLA, which in turn drives the price of the stock up even further. How often is Estrella Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESLA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Molecular Partners Short Interest Data Vigil Neuroscience Short Interest Data aTyr Pharma Short Interest Data Sangamo Therapeutics Short Interest Data DBV Technologies Short Interest Data Omega Therapeutics Short Interest Data bluebird bio Short Interest Data Cognition Therapeutics Short Interest Data Athira Pharma Short Interest Data Precision BioSciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ESLA) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeThis unknown company solves the biggest issue with AIManward PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.